| 【行业研究】中国互联网 – 元宇宙：数字经济下一站 |
| 【Company Research】Kintor Pharmaceutical (9939 HK) – Continue to pursue the development of proxalutamide for treatment of COVID-19 |
| 【Company Research】Jinxin Fertility (1951 HK) – Core emphasis on provision of high quality medical services |
| 【Company Research】Jinxin Fertility (1951 HK) – Core emphasis on provision of high quality medical services |
| 【Company Research】Excellence Commercial Property (6989 HK) – Asset sale will not affect guidance |
| 【Company Research】I-Mab BioPharma (IMAB US) – Appointment of a globally renowned oncologist to lead the R&D organization |
| 【Company Research】ANE (9956 HK) – Largest express freight network operator in China LTL market |
| 【Sector Research】China Banking Sector – Implications of 5 bps cut on 1-yr LPR |
| 【Company Research】Vesync (2148 HK) – FY22E guidance maintained but we are prudent |
| 【Fixed Income Research】SAKAEI – Saka Energi Coverage Initiation |
Address: 45th & 46th Floor, Champion Tower, 3 Garden Road, Central, Hong Kong
Telephone: （852）3900 0888 Fax:（852）3761 8788
Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
